StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3039% above fair value
$610.54−23.44 (-3.70%)

Close on Nov 20, 2026Market cap $17.08BP/E 33.9Yield –

Medpace shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Medpace's shares outstanding was 28M at Sep 30, 2026. For fiscal 2025 it was 30M, down 7.8% from the year before. Over ten years it grew -0.6% a year on average. The highest annual figure on record is 40M in fiscal 2017.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202530M-7.8%
FY2024Dec 31, 202432M+0.5%
FY2023Dec 31, 202332M-5.4%
FY2022Dec 31, 202234M-10.7%
FY2021Dec 31, 202138M-0.0%
FY2020Dec 31, 202038M+0.4%
FY2019Dec 31, 201938M+1.8%
FY2018Dec 31, 201837M-7.3%
FY2017Dec 31, 201740M+9.7%
FY2016Dec 31, 201636M+15.9%
FY2015Dec 31, 201531M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202628M-1.5%
Q2 FY2026Jun 30, 202629M-2.0%
Q1 FY2026Mar 31, 202629M-7.2%
Q4 FY2025Dec 31, 202529M-9.1%
Q3 FY2025Sep 30, 202529M-10.2%
Q2 FY2025Jun 30, 202529M-9.2%
Q1 FY2025Mar 31, 202531M-2.5%
Q4 FY2024Dec 31, 202432M+0.1%
Q3 FY2024Sep 30, 202432M+1.0%
Q2 FY2024Jun 30, 202432M+1.6%
Q1 FY2024Mar 31, 202432M-0.5%
Q4 FY2023Dec 31, 202332M-1.7%
Q3 FY2023Sep 30, 202332M-1.5%
Q2 FY2023Jun 30, 202332M-6.3%
Q1 FY2023Mar 31, 202332M-11.6%
Q4 FY2022Dec 31, 202232M-14.5%
Q3 FY2022Sep 30, 202232M-14.0%
Q2 FY2022Jun 30, 202234M-10.7%
Q1 FY2022Mar 31, 202236M-3.7%
Q4 FY2021Dec 31, 202138M+0.5%
Q3 FY2021Sep 30, 202138M-0.6%
Q2 FY2021Jun 30, 202138M+1.0%
Q1 FY2021Mar 31, 202138M-0.7%
Q4 FY2020Dec 31, 202038M-0.3%
Q3 FY2020Sep 30, 202038M-0.2%
Q2 FY2020Jun 30, 202037M-0.2%
Q1 FY2020Mar 31, 202038M+2.0%
Q4 FY2019Dec 31, 201938M+1.4%
Q3 FY2019Sep 30, 201938M+1.9%
Q2 FY2019Jun 30, 201937M+2.0%
Q1 FY2019Mar 31, 201937M+2.3%
Q4 FY2018Dec 31, 201837M-1.3%
Q3 FY2018Sep 30, 201837M-5.6%
Q2 FY2018Jun 30, 201837M-10.2%
Q1 FY2018Mar 31, 201836M-12.2%
Q4 FY2017Dec 31, 201738M-10.6%
Q3 FY2017Sep 30, 201739M–
Q2 FY2017Jun 30, 201741M–
Q1 FY2017Mar 31, 201742M–
Q4 FY2016Dec 31, 201642M–

More Medpace figures

See a number that looks wrong?